In conclusion, our study is the first to depict a scenario in which oncolipid (LPA) signaling leads to metabolic plasticity in ovarian cancer cells towards reduced mitochondrial oxidative phosphorylation, as well as increased glycolysis through the pro‐metastatic protein ETS‐1. The gene discussed is ETS1; the disease is ovarian cancer.